Literature DB >> 6222087

Penicillamine: review and cutaneous manifestations.

R S Levy, M Fisher, J N Alter.   

Abstract

D-Penicillamine, a heavy metal chelator used in the treatment of Wilson's disease and other conditions, may be associated with both noncutaneous and cutaneous side effects. Some of the cutaneous lesions are due to a toxic-metabolic effect on connective tissue; some may be explained on the basis of autoimmunity; some are acute sensitivity reactions, and some are secondary to unknown mechanisms. The types of cutaneous manifestations may, in some instances, be correlated with the disease being treated and the dosage and duration of penicillamine therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222087     DOI: 10.1016/s0190-9622(83)70062-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

Review 1.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

2.  Development of morphoea in rheumatoid arthritis treated with penicillamine.

Authors:  B J Liddle
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

3.  Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome.

Authors:  Jin-Wuk Hur; Chang-Woo Lee; Dae-Hyun Yoo
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

4.  D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis.

Authors:  Shuxi Qiao; Christopher M Cabello; Sarah D Lamore; Jessica L Lesson; Georg T Wondrak
Journal:  Apoptosis       Date:  2012-10       Impact factor: 4.677

5.  Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy.

Authors:  Kavita Gaur; Alexandra M Vázquez-Salgado; Geraldo Duran-Camacho; Irivette Dominguez-Martinez; Josué A Benjamín-Rivera; Lauren Fernández-Vega; Lesly Carmona Sarabia; Angelys Cruz García; Felipe Pérez-Deliz; José A Méndez Román; Melissa Vega-Cartagena; Sergio A Loza-Rosas; Xaymara Rodriguez Acevedo; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2018-11-30

Review 6.  D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.

Authors:  Michela Pugliese; Vito Biondi; Enrico Gugliandolo; Patrizia Licata; Alessio Filippo Peritore; Rosalia Crupi; Annamaria Passantino
Journal:  Antibiotics (Basel)       Date:  2021-05-28

7.  D-penicillamine Induced Degenerative Dermopathy.

Authors:  Sujay Khandpur; Naresh Jain; Shweta Singla; Priti Chatterjee; Madhuri Behari
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.